MedPath

the effect of Nebulized Hypertonic3% Saline in the Treatment of Acute bronchiolitis in pediatric ward

Phase 2
Conditions
brochiolitis.
Acute bronchiolitis due to respiratory syncytial virus
Registration Number
IRCT2012110510222N2
Lead Sponsor
Vice Chancellor for Research, Shahrekord Univrsity of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
70
Inclusion Criteria

diagnosis of bronchiolitis, admission in Pediatric ward,
Exclusion criteria:any underlying
disease (e.g., cystic fibrosis, bronchopulmonary dysplasia
and cardiac or renal disease, wheezing,
atopic dermatitis, allergic rhinitis or asthma, oxygen
saturation (SaO2) <85% on room air, progressive respiratory failure
requiring mechanical ventilation, previous treatment with
bronchodilators, and any steroid therapy within 2 weeks.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bronchiolitis symptom. Timepoint: at base line, two weeks later. Method of measurement: examination.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath